Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Newly initiated Moderna clinical studies in period by Year
Newly initiated Moderna clinical studies in period (studies)
Moderna Newly initiated Moderna clinical studies in period: 13.00 studies in FY2025, down 23.5% from a year earlier.
Where the FY2025 figure comes from
Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Newly initiated Moderna clinical studies in period (studies) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13.00 | -23.5% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2024 | Dec 31, 2024 | 17.00 | -43.3% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2023 | Dec 31, 2023 | 30.00 | +11.1% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2022 | Dec 31, 2022 | 27.00 | +12.5% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2021 | Dec 31, 2021 | 24.00 | +242.9% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2020 | Dec 31, 2020 | 7.00 | +16.7% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2019 | Dec 31, 2019 | 6.00 | +200.0% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2018 | Dec 31, 2018 | 2.00 | – | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
Breakdown
What makes up newly initiated Moderna clinical studies in period
Cite this data
StockData. (2026). Moderna Newly initiated Moderna clinical studies in period, annual FY2018–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-new-studies
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.